Human Ornithine Aminotransferase cocrystallized with its inhibitor, (S,E)-3-amino-4-(fluoromethylene)cyclopent-1-ene-1-carboxylate

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Welcome
RCSB PDB Mol* Viewer 2.11.2 [1/27/2025, 4:56:27 PM]
Sequence of
36   ​G​​P​​P​​T​​S​​D​​D​​I​​F​​E​46   ​R​​E​​Y​​K​​Y​​G​​A​​H​​N​​Y​56   ​H​​P​​L​​P​​V​​A​​L​​E​​R​​G​66   ​K​​G​​I​​Y​​L​​W​​D​​V​​E​​G​76   ​R​​K​​Y​​F​​D​​F​​L​​S​​S​​Y​86   ​S​​A​​V​​N​​Q​​G​​H​​C​​H​​P​96   ​K​​I​​V​​N​​A​​L​​K​​S​​Q​​V​106  ​D​​K​​L​​T​​L​​T​​S​​R​​A​​F​116  ​Y​​N​​N​​V​​L​​G​​E​​Y​​E​​E​126  ​Y​​I​​T​​K​​L​​F​​N​​Y​​H​​K​136  ​V​​L​​P​​M​​N​​T​​G​​V​​E​​A​146  ​G​​E​​T​​A​​C​​K​​L​​A​​R​​K​156  ​W​​G​​Y​​T​​V​​K​​G​​I​​Q​​K​166  ​Y​​K​​A​​K​​I​​V​​F​​A​​A​​G​176  ​N​​F​​W​​G​​R​​T​​L​​S​​A​​I​186  ​S​​S​​S​​T​​D​​P​​T​​S​​Y​​D​196  ​G​​F​​G​​P​​F​​M​​P​​G​​F​​D​206  ​I​​I​​P​​Y​​N​​D​​L​​P​​A​​L​216  ​E​​R​​A​​L​​Q​​D​​P​​N​​V​​A​226  ​A​​F​​M​​V​​E​​P​​I​​Q​​G​​E​236  ​A​​G​​V​​V​​V​​P​​D​​P​​G​​Y​246  ​L​​M​​G​​V​​R​​E​​L​​C​​T​​R​256  ​H​​Q​​V​​L​​F​​I​​A​​D​​E​​I​266  ​Q​​T​​G​​L​​A​​R​​T​​G​​R​​W​276  ​L​​A​​V​​D​​Y​​E​​N​​V​​R​​P​286  ​D​​I​​V​​L​​L​​G​​K​​A​​L​​S​296  ​G​​G​​L​​Y​​P​​V​​S​​A​​V​​L​306  ​C​​D​​D​​D​​I​​M​​L​​T​​I​​K​316  ​P​​G​​E​​H​​G​​S​​T​​Y​​G​​G​326  ​N​​P​​L​​G​​C​​R​​V​​A​​I​​A​336  ​A​​L​​E​​V​​L​​E​​E​​E​​N​​L​346  ​A​​E​​N​​A​​D​​K​​L​​G​​I​​I​356  ​L​​R​​N​​E​​L​​M​​K​​L​​P​​S​366  ​D​​V​​V​​T​​A​​V​​R​​G​​K​​G​376  ​L​​L​​N​​A​​I​​V​​I​​K​​E​​T​386  ​K​​D​​W​​D​​A​​W​​K​​V​​C​​L​396  ​R​​L​​R​​D​​N​​G​​L​​L​​A​​K​406  ​P​​T​​H​​G​​D​​I​​I​​R​​F​​A​416  ​P​​P​​L​​V​​I​​K​​E​​D​​E​​L​426  ​R​​E​​S​​I​​E​​I​​I​​N​​K​​T​436  ​I​​L​​S​​F​
Type
Asm Id
Dynamic Bonds
Symmetry Index

Select a different viewer

Citation:

See Citation Policies for referencing Mol*, RCSB PDB, PDB structures, and Computed Structure Models.